Drugs / Alvogyl
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06823544 | Feb → Jul 2025 overdue | alveolar periostitis | HITEC-Institute of Medical Sciences | Not yet recruiting | No outcome recorded |
| Phase 42 trials · 1 missed | ||||||
| Phase 4 | NCT06144983 | Feb → Sep 2022 | impacted teeth, multiple | University of Baghdad | Completed | No outcome recorded |
| Phase 4 | NCT03402321 | Apr → Jun 2019 | — | Karim ehab gerges | Unknown | Missed primary |
| Phase not applicable1 trial | ||||||
| — | NCT07790653 | Feb → Sep 2026 overdue | alveolar periostitis | CMH Lahore Medical College and Institute of Dentistry | Active not recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06456060 Comparator | Jun → Dec 2024 overdue | alveolar periostitis | Watim Medical & Dental College | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alvogyl | “Alvogyl is a commonly used dressing for managing dry socket and can provide rapid pain relief.” NCT07790653 ↗ |
| Route | Other | “was inserted inside the alveolus” NCT06144983 ↗ |